Evidence map›Paper›PMID 39241904›Full record

Observational studyContraception2025

Selection of long acting reversible contraception methods by emergency contraception clients: A prospective observational study.

Gentry Carter, Misha Pangasa, Corinne D Sexsmith, Sarah Elliott, David K Turok, Lori M Gawron

Registry-linked trialAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Contraception, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04678817 (A Prospective Observational Study of Preference for and Efficacy of Oral Levonorgestrel Emergency Contraception With Same Day Etonogestrel Contraceptive Implant Compared to Established Pregnancy Rates With Oral Levonorgestrel Emergency Contraception Alone), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04678817 completednot on this map

A Prospective Observational Study of Preference for and Efficacy of Oral Levonorgestrel Emergency Contraception With Same Day Etonogestrel Contraceptive Implant Compared to Established Pregnancy Rates With Oral Levonorgestrel Emergency Contraception Alone

TypeobservationalSponsorUniversity of UtahRan2021 to 2024Enrolled306ConditionsContraceptionArmsEtonogestrel contraceptive implant with oral levonorgestrel, Levonorgestrel intrauterine device, Copper T380A intrauterine device
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gentry CarterASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
Misha PangasaASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
Corinne D SexsmithASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
Sarah ElliottASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
David K TurokASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
Lori M GawronASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States. Electronic address: lori.gawron@hsc.utah.edu.

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
University of Utah Center for Clinical and Translational ScienceUL1TR001067 · NCATS · UNIVERSITY OF UTAH · PI DERE, WILLARD H., HESS, RACHEL · 2013 to 2017
$19.8M
Midcareer Investigator Award in Patient-Oriented Research K24K24HD087436 · NICHD · UNIVERSITY OF UTAH · PI TUROK, DAVID · 2017 to 2021
$942k
NCATS NIH HHS UL1 TR001067NCATS NIH HHS UL1 TR002538NCATS NIH HHS UM1 TR004409NICHD NIH HHS K24 HD087436
6 · The paper itself

Abstract

objectivesTo describe long acting reversible contraception (LARC) initiation in emergency contraception (EC) visits. STUDY

designEC clients age 18-35 years at four Utah family planning clinics between February 2021 and April 2023 chose between oral EC and three LARC options.

resultsOf 2106 EC clients approached, 306 (14.5%) requested LARC and 293 initiated a device: 160 (55%) an etonogestrel implant+ oral levonorgestrel (LNG), 72 (25%) a copper intrauterine device (IUD), and 61 (21%) a 52 mg levonorgestrel IUD (p < 0.001).

conclusionsIn this observational study, one in seven EC clients initiated a LARC method and more frequently selected the etonogestrel implant with oral levonorgestrel over an IUD. CLINICAL

trial registrationClinicaltrials.gov NCT04678817; registered 12/16/20.

Indexed as

Contraception, PostcoitalDesogestrelIntrauterine Devices, CopperLevonorgestrelLong-Acting Reversible ContraceptionAdolescentAdultContraceptive Agents, FemaleDrug ImplantsFemaleHumansProspective StudiesUtahYoung AdultContraceptive Agents, FemaleDesogestrelDrug ImplantsetonogestrelLevonorgestrelEmergency contraceptionEtonogestrel implantIUDLARC

Identifiers

PMID39241904
PMCPMC12543270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.